Open Orphan plc changes its name to hVIVO plc, learn more here.

Phase II-III Clinical Trials

Vaccine Trials Overview

Vaccine Development Expertise

Having a long-lasting experience and expertise in virology and vaccine development, we understand the unique needs of Pharma and Biotech clients and accelerate vaccine development with our fast recruitment capabilities and dedicated resources. Depending on the sample size of your vaccine clinical trial and specific healthy subject population, we can act as a single-site or as one of the sites in multicentre Phase II-III clinical trials.




End-to-end Consulting

We have a team of virology and immunology experts, scientists and clinicians on board to support you with the study design, advise on most relevant endpoints and address specific questions related to your unique vaccine candidate. Our regulatory team helps you manage clinical trial application submissions and interactions with competent authorities and regulatory bodies.


Healthy Volunteer Recruitment

One of the core aspects in a highly competitive vaccine development environment is study timelines. We ensure expedited subject recruitment through our specialized volunteer recruitment arm, FluCamp. With extensive healthy volunteer database of over 250k, enormous screening capacities of around 1k subjects/week, decades of experience attracting suitable healthy subjects via multichannel approach and tech-enabled platform, we meet your recruitment requirements and timelines with each and every study we conduct.


In-house Virology Lab

Our specialized laboratory hLAB offers a suite of services to support clinical vaccine development. Reliable laboratory analysis underpinned by scientific expertise is essential when processing and analysing clinical samples. Robust quality processes support our team of scientists in the delivery of submission ready data.

Clinical Development Experience

CLINICAL TRIALS COMPLETED
0
HEALTHY VOLUNTEERS ENROLLED
0
VACCINE CLINICAL TRIALS COMPLETED
0

Vaccine development capabilities against pathogens:

Influenza

SARS CoV-2

RSV

Malaria

Dengue

Human Rhinovirus

Hmpv

Herpes virus

Adenovirus

Hepatitis virus

Ebola virus

Rabies virus

Rubella virus

Rotavirus

Zika virus

Cytomegalovirus

Chikungunya virus

Enterovirus

Streptococcal infections

Monkeypox

hVIVO Advantage

Therapeutically focused commercial site

Experienced scientific and clinical teams

Thorough experience in vaccine trials

FluCamp 
Dedicated healthy volunteer recruitment

250.000+
Healthy volunteer database

hLAB 
Specialized on-site virology immunology lab 

Supporting Services

Our team develops a broad range of regulatory documents: from Scientific Advice briefing packages over IND submission documents to clinical study reports

hVIVO’s extensive expertise in human challenge trials and vaccine trials allows the company to provide you with the support and management you need to ensure your trial is performed correctly and in a timely manner

Our statistics, study design and methodology services are available to optimise the design of your trial

hVIVO can enhance the quality of your trials through accurate identification & selection

We can collect, keep and use all data in a secure & efficiently manner from the help of our experts in the field with vast experience within the industry.

Interesting learning on the use of generic screening process
US Biotech client

Interested to learn more about our capabilities in Phase II-III Vaccine Studies? 
Do not hesitate to contact us.

Contact hVIVO
chevron-down